Table 3 Subgroup analysis of perioperative outcomes between LA LSPDP and CA LSPDP groups stratified by obesity.
LA LSPDP (N = 26) | CA LSPDP (N = 29) | P-value | |
|---|---|---|---|
Conversion to open surgery, N (%) | 0 | 0 | |
Conversion to Warshaw’s technique, N (%) | 5 (19.2) | 9 (31.0) | 0.316 |
Conversion to distal pancreatectomy, N (%) | 3 (11.5) | 10 (34.5) | 0.046 |
Whole operation time, min | 133.6 ± 63.38 | 166.8 ± 51.87 | 0.038 |
Estimated blood loss, cc | 137.9 ± 179.92 | 388.6 ± 444.85 | 0.008 |
Transfusion, N (%) | 0 | 3 (10.3) | 0.238 |
CR-POPF | 2 (7.7) | 4 (13.8) | 0.672 |
Days until drain removal | 8 ± 5.15 | 12.4 ± 15.81 | 0.177 |
Postoperative complication, N (%) | |||
Atelectasis | 13 (50) | 7 (24.1) | 0.047 |
Pneumonia | 0 | 1 (3.4) | 1.000 |
PPH | 0 | 0 | |
DGE | 0 | 0 | |
Wound infection | 0 | 2 (6.9) | 0.492 |
Clavien-Dindo classification, N (%) | 0.819 | ||
Minor | 11 (42.3) | 8 (27.6) | |
Major | 2 (7.7) | 5 (17.2) | |
Reoperation | 0 | 0 | |
Re-admission, N(%) | 1 (3.8) | 3 (10.3) | 0.613 |
Morbidity, N(%) | 13 (50) | 8 (28.6) | 0.107 |
Mortality (< 90 days), N (%) | 0 | 1 (3.6) | 1.000 |
Length of hospital stay, day | 7.8 ± 1.37 | 8 ± 2.41 | 0.66 |
